No insider purchase over the last 90 days. The latest, by Zankhana Nipambhai Jani, was filed 05 Mar 2025.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
25 of 36 declarations
Accent Microcell Limited, an Indian healthcare company listed in Bombay with a market capitalisation of INR 15,424.9 million, only appears in the filings from January 2024. Between January 16 and January 19, 2024, 12 insiders bought, for EUR 549,018 in total: this is the busiest window on file, with 22 purchase filings grouped around it.
In all there are 23 purchases worth EUR 957,456 (median EUR 28,100) and 6 sales, 4 of them with an amount, worth EUR 59,186 (median EUR 9,222), or 79% purchases among open-market trades. The three largest purchases date from March 14, 2024: Nitin Jasvantbhai Patel for EUR 136,634, Ghanshyambhai Arjanbhai Patel for EUR 129,732 and Shaileshbhai Arjanbhai Patel for EUR 74,082. The largest sale is Adwait Artha LLP's, EUR 34,413 on March 5, 2025, followed by EUR 11,306 on March 10.
Of the 36 filings, 24 date from 2024, 10 from 2025 and 2 from 2026, and the 2 within the last twelve months are sales. Filings appear a median of one day after the trade. For the 23 purchases a 90-day result is stored: a median of -15.8%, with 39% of results positive (recorded past results, not a forecast).